Pharmacogenomics in cancer drug discovery and development: inhibitors of the Hsp90 molecular chaperone.

@article{Workman2002PharmacogenomicsIC,
  title={Pharmacogenomics in cancer drug discovery and development: inhibitors of the Hsp90 molecular chaperone.},
  author={Paul Workman},
  journal={Cancer detection and prevention},
  year={2002},
  volume={26 6},
  pages={
          405-10
        }
}
Drug discovery is being revolutionised by a number of technological developments. These include high throughput screening, combinatorial chemistry and genomics. The impact of the new technologies is to accelerate the pace of anticancer discovery. The completion of the Human Genome Project and the ongoing high throughput sequencing of cancer genomes will facilitate the identification of a range of new molecular targets for drug discovery. Over the next few years we will have a complete molecular… CONTINUE READING
BETA

Citations

Publications citing this paper.

Similar Papers